Cleave Therapeutics

0 followers


Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases.

Employees

1-10

Links


Org chart

Amy Burroughs
President & CEO
Collapse
No reports!

Board & advisors

Jon Root
Director
John Gutheil
Development Advisor
James Kanter
Business Advisor
Dina Gonzalez
Business Advisor
Erica Pascal
Business Advisor
Monic Stuart
Development Advisor